Joseph F. Lawler
Board Member
Anebulo Pharmaceuticals, Inc. (ANEB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph F. Lawler
Joseph F. Lawler is recorded as Board Member at Anebulo Pharmaceuticals, Inc. (ANEB). Anebulo Pharmaceuticals, Inc. reported in an 8-K filed April 7, 2025 that Joseph F. Lawler was appointed Class I Director, effective April 4, 2025.
“The stockholders elected each of Joseph F. Lawler, Richard Anthony Cunningham, and Aron R. English to serve on the Board the terms of each, along with all other directors, will end at the annual meeting of stockholders of the Company that is held after the filing of the Declassification Charter Amendment (the “Initial Declassified Annual Meeting”), and commencing with the Initial Declassified Annual Meeting, all directors will stand for election at the Initial Declassified Annual Meeting for one-year terms.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-04-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Anebulo Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Richard (Richie) Anthony Cunningham CEO, Board Member
- Richard Anthony Cunningham CEO, Board Member
- Daniel George CFO, Chief Accounting Officer
- Sandra A. Gardiner CFO, Chief Accounting Officer
- Aron R. English Board Member
- Bimal Shah Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.